mebendazole has been researched along with Cancer of Mouth in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kralova, V | 1 |
| Hanušová, V | 1 |
| Caltová, K | 1 |
| Špaček, P | 1 |
| Hochmalová, M | 1 |
| Skálová, L | 1 |
| Rudolf, E | 1 |
1 other study available for mebendazole and Cancer of Mouth
| Article | Year |
|---|---|
Flubendazole and mebendazole impair migration and epithelial to mesenchymal transition in oral cell lines.
Topics: Cadherins; Carcinoma, Squamous Cell; cdc42 GTP-Binding Protein; Cell Line; Cell Movement; Cell Proli | 2018 |